Skip to main content
FHTX
NASDAQ Life Sciences

Foghorn Swings to $58.2M Q3 Profit on $74.1M Catch-Up Adjustment, Cash Runway to 2029

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.87
Mkt Cap
$111.051M
52W Low
$1.79
52W High
$7.61
52W Position info
4.5% above low
Off High info
75% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

FHTX is trading near its 52-week low of $1.79 (4.5% above the low).

Summary

Foghorn posted Q3 collaboration revenue of $83.5M and EPS of $0.80, swinging to $58.2M of net income from a loss a year earlier. The profit is almost entirely accounting: a $74.1M cumulative catch-up adjustment tied to updated estimated future costs for the discontinued Lilly programs, not new cash coming in. The real substance is the balance sheet — $156M in cash funds operations into the second half of 2029, a long runway for a company trading near its 52-week low. R&D and G&A fell year over year on lower partnered-program, personnel and facilities costs after the October restructuring that cut 40% of the workforce. Pipeline milestones ahead: dose-range finding studies for the IBD program start in Q4 2026, first-in-human IBD trials are targeted by end of 2027, and an IND for the EP300 degrader is planned for 2027.

At the time of this announcement, FHTX was trading at $1.87 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $111.1M. The 52-week trading range was $1.79 to $7.61. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

FHTX - Latest Insights

FHTX
Nov 09, 2026, 7:06 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.87
Real-time Price: $2.09 info
Change: +$0.220 (+12%) info
Market Cap: $125.322M info
FHTX
Oct 01, 2026, 7:01 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.57
Real-time Price: $2.09 info
Change: -$1.48 (-41%) info
Market Cap: $125.322M info
FHTX
Oct 01, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $3.57
Real-time Price: $2.09 info
Change: -$1.48 (-41%) info
Market Cap: $125.322M info
FHTX
May 07, 2026, 7:11 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $4.68
Real-time Price: $2.09 info
Change: -$2.59 (-55%) info
Market Cap: $125.322M info
FHTX
May 07, 2026, 7:02 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.68
Real-time Price: $2.09 info
Change: -$2.59 (-55%) info
Market Cap: $125.322M info